Annual CFO:
$295.03M+$111.87M(+61.07%)Summary
- As of today, AMRX annual cash from operations is $295.03 million, with the most recent change of +$111.87 million (+61.07%) on December 31, 2024.
- During the last 3 years, AMRX annual cash from operations has risen by +$53.21 million (+22.00%).
- AMRX annual cash from operations is now -22.16% below its all-time high of $379.00 million, reached on December 31, 2020.
Performance
AMRX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$83.82M+$76.41M(+1031.47%)Summary
- As of today, AMRX quarterly cash from operations is $83.82 million, with the most recent change of +$76.41 million (+1031.47%) on June 30, 2025.
- Over the past year, AMRX quarterly cash from operations has increased by +$44.16 million (+111.36%).
- AMRX quarterly cash from operations is now -67.72% below its all-time high of $259.65 million, reached on December 31, 2018.
Performance
AMRX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$351.01M+$44.16M(+14.39%)Summary
- As of today, AMRX TTM cash from operations is $351.01 million, with the most recent change of +$44.16 million (+14.39%) on June 30, 2025.
- Over the past year, AMRX TTM cash from operations has increased by +$260.97 million (+289.83%).
- AMRX TTM cash from operations is now -26.58% below its all-time high of $478.10 million, reached on March 31, 2021.
Performance
AMRX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AMRX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +61.1% | +111.4% | +289.8% |
| 3Y3 Years | +22.0% | +202.8% | +149.9% |
| 5Y5 Years | +10000.0% | -53.2% | +58.0% |
AMRX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +365.1% | -40.9% | +421.8% | at high | +799.1% |
| 5Y | 5-Year | -22.2% | >+9999.0% | -43.4% | +202.8% | -26.6% | +799.1% |
| All-Time | All-Time | -22.2% | +1634.8% | -67.7% | +177.3% | -26.6% | +1376.3% |
AMRX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $83.82M(+1031.5%) | $351.01M(+14.4%) |
| Mar 2025 | - | $7.41M(-93.7%) | $306.85M(+4.0%) |
| Dec 2024 | $295.03M(+61.1%) | $118.01M(-16.8%) | $295.03M(+95.4%) |
| Sep 2024 | - | $141.77M(+257.5%) | $150.97M(+67.7%) |
| Jun 2024 | - | $39.66M(+999.3%) | $90.04M(+130.6%) |
| Mar 2024 | - | -$4.41M(+83.1%) | $39.04M(-78.7%) |
| Dec 2023 | $183.16M(+188.7%) | -$26.05M(-132.2%) | $183.16M(-1.5%) |
| Sep 2023 | - | $80.84M(+812.6%) | $185.92M(-6.4%) |
| Jun 2023 | - | -$11.35M(-108.1%) | $198.65M(+54.6%) |
| Mar 2023 | - | $139.71M(+699.8%) | $128.47M(+97.3%) |
| Dec 2022 | $63.44M(-73.8%) | -$23.29M(-124.9%) | $65.10M(-57.1%) |
| Sep 2022 | - | $93.57M(+214.8%) | $151.65M(+8.0%) |
| Jun 2022 | - | -$81.52M(-206.8%) | $140.45M(-17.4%) |
| Mar 2022 | - | $76.34M(+20.7%) | $170.04M(-29.7%) |
| Dec 2021 | $241.82M(-36.2%) | $63.26M(-23.2%) | $241.82M(-15.0%) |
| Sep 2021 | - | $82.36M(+258.6%) | $284.52M(+15.2%) |
| Jun 2021 | - | -$51.93M(-135.1%) | $246.93M(-48.4%) |
| Mar 2021 | - | $148.13M(+39.8%) | $478.10M(+26.1%) |
| Dec 2020 | $379.00M(>+9900.0%) | $105.96M(+136.6%) | $379.00M(+70.6%) |
| Sep 2020 | - | $44.78M(-75.0%) | $222.15M(-30.0%) |
| Jun 2020 | - | $179.24M(+265.6%) | $317.29M(+99.4%) |
| Mar 2020 | - | $49.03M(+196.3%) | $159.14M(+9233.8%) |
| Dec 2019 | $1.71M(-99.3%) | -$50.89M(-136.4%) | $1.71M(-99.5%) |
| Sep 2019 | - | $139.91M(+563.3%) | $312.25M(+33.2%) |
| Jun 2019 | - | $21.09M(+119.5%) | $234.46M(+104.3%) |
| Mar 2019 | - | -$108.41M(-141.8%) | $114.79M(-54.1%) |
| Dec 2018 | $250.23M(+6.9%) | $259.65M(+317.9%) | $250.23M(+311.1%) |
| Sep 2018 | - | $62.13M(+163.0%) | $60.87M(-9.5%) |
| Jun 2018 | - | -$98.58M(-464.7%) | $67.23M(-59.5%) |
| Mar 2018 | - | $27.03M(-61.5%) | $165.81M(+19.5%) |
| Dec 2017 | $234.19M(+213.9%) | $70.29M(+2.6%) | $138.78M(+206.2%) |
| Sep 2017 | - | $68.49M(+395.6%) | $45.32M(-39.3%) |
| Dec 2016 | $74.60M(+3.7%) | - | - |
| Dec 2016 | - | -$23.17M(-131.3%) | $74.60M(-44.6%) |
| Sep 2016 | - | $73.98M(+237.8%) | $134.62M(+4.9%) |
| Jun 2016 | - | -$53.67M(-169.3%) | $128.29M(+2.0%) |
| Mar 2016 | - | $77.46M(+110.2%) | $125.73M(+74.8%) |
| Dec 2015 | $71.93M(+119.2%) | $36.85M(-45.5%) | $71.93M(+415.5%) |
| Sep 2015 | - | $67.66M(+220.3%) | $13.95M(+214.5%) |
| Jun 2015 | - | -$56.24M(-337.7%) | -$12.19M(-116.6%) |
| Mar 2015 | - | $23.66M(+212.0%) | $73.55M(+124.1%) |
| Dec 2014 | $32.82M(-78.1%) | -$21.12M(-150.9%) | $32.82M(-32.5%) |
| Sep 2014 | - | $41.52M(+40.8%) | $48.61M(+900.2%) |
| Jun 2014 | - | $29.50M(+272.7%) | -$6.08M(-108.1%) |
| Mar 2014 | - | -$17.08M(-220.6%) | $75.12M(-49.9%) |
| Dec 2013 | $149.94M | -$5.33M(+59.6%) | $149.94M(+31.3%) |
| Sep 2013 | - | -$13.17M(-111.9%) | $114.19M(-41.5%) |
| Jun 2013 | - | $110.69M(+91.7%) | $195.31M(+39.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $57.75M(+240.6%) | $140.23M(+32.0%) |
| Dec 2012 | $106.21M(+1570.5%) | -$41.08M(-160.4%) | $106.21M(-25.8%) |
| Sep 2012 | - | $67.96M(+22.2%) | $143.19M(+41.9%) |
| Jun 2012 | - | $55.60M(+134.3%) | $100.93M(+247.1%) |
| Mar 2012 | - | $23.73M(+679.3%) | $29.08M(+357.3%) |
| Dec 2011 | $6.36M(-97.5%) | -$4.10M(-115.9%) | $6.36M(+1826.7%) |
| Sep 2011 | - | $25.70M(+258.1%) | $330.00K(-94.8%) |
| Jun 2011 | - | -$16.25M(-1707.7%) | $6.40M(-97.0%) |
| Mar 2011 | - | $1.01M(+110.0%) | $213.16M(-14.7%) |
| Dec 2010 | $249.76M(+3161.9%) | -$10.12M(-131.9%) | $249.76M(-1.7%) |
| Sep 2010 | - | $31.77M(-83.3%) | $254.09M(+14.4%) |
| Jun 2010 | - | $190.50M(+406.5%) | $222.02M(+367.0%) |
| Mar 2010 | - | $37.61M(+749.6%) | $47.54M(+682.8%) |
| Dec 2009 | -$8.16M(-112.6%) | -$5.79M(-1779.9%) | -$8.16M(-120.0%) |
| Sep 2009 | - | -$308.00K(-101.9%) | $40.78M(+16.3%) |
| Jun 2009 | - | $16.02M(+188.6%) | $35.08M(+84.1%) |
| Mar 2009 | - | -$18.08M(-141.9%) | $19.06M(-48.7%) |
| Dec 2008 | $64.56M(-45.8%) | $43.15M(+818.0%) | $37.14M(+718.0%) |
| Sep 2008 | - | -$6.01M(+6.2%) | -$6.01M(+78.1%) |
| Dec 2007 | $119.01M(+2166.2%) | - | - |
| Dec 2006 | -$5.76M(-127.2%) | - | - |
| Dec 2005 | $21.15M(+210.0%) | - | - |
| Sep 2004 | - | -$6.41M(+61.6%) | -$27.50M(-20.9%) |
| Jun 2004 | - | -$16.68M(-434.8%) | -$22.75M(-70.2%) |
| Mar 2004 | - | $4.98M(+153.0%) | -$13.37M(+30.4%) |
| Dec 2003 | -$19.22M(-26.5%) | -$9.40M(-466.9%) | -$19.22M(-15.2%) |
| Sep 2003 | - | -$1.66M(+77.3%) | -$16.68M(-10.4%) |
| Jun 2003 | - | -$7.29M(-737.4%) | -$15.11M(-16.7%) |
| Mar 2003 | - | -$871.00K(+87.3%) | -$12.95M(+14.8%) |
| Dec 2002 | -$15.20M(+15.0%) | -$6.86M(-7606.7%) | -$15.20M(-18.7%) |
| Sep 2002 | - | -$89.00K(+98.3%) | -$12.81M(+23.2%) |
| Jun 2002 | - | -$5.13M(-64.0%) | -$16.68M(-1.2%) |
| Mar 2002 | - | -$3.13M(+30.0%) | -$16.48M(+7.8%) |
| Dec 2001 | -$17.88M(-11.7%) | -$4.47M(-12.8%) | -$17.88M(-4.9%) |
| Sep 2001 | - | -$3.96M(+19.6%) | -$17.03M(+1.4%) |
| Jun 2001 | - | -$4.92M(-8.8%) | -$17.28M(+3.6%) |
| Mar 2001 | - | -$4.53M(-24.9%) | -$17.92M(-12.0%) |
| Dec 2000 | -$16.00M(-137.6%) | -$3.62M(+13.9%) | -$16.00M(-2.8%) |
| Sep 2000 | - | -$4.21M(+24.4%) | -$15.56M(-25.2%) |
| Jun 2000 | - | -$5.56M(-113.2%) | -$12.43M(-60.5%) |
| Mar 2000 | - | -$2.61M(+18.1%) | -$7.74M(-14.9%) |
| Dec 1999 | -$6.74M(-49.0%) | -$3.19M(-197.1%) | -$6.74M(-76.5%) |
| Sep 1999 | - | -$1.07M(-22.2%) | -$3.82M(-1.5%) |
| Jun 1999 | - | -$877.00K(+45.3%) | -$3.76M(+19.5%) |
| Mar 1999 | - | -$1.60M(-502.6%) | -$4.67M(-3.3%) |
| Dec 1998 | -$4.52M | -$266.00K(+73.8%) | -$4.52M(-6.3%) |
| Sep 1998 | - | -$1.01M(+43.3%) | -$4.26M(-31.3%) |
| Jun 1998 | - | -$1.79M(-23.1%) | -$3.24M(-123.1%) |
| Mar 1998 | - | -$1.45M | -$1.45M |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual cash from operations year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
- What is Amneal Pharmaceuticals, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual cash from operations?
The current annual cash from operations of AMRX is $295.03M
What is the all-time high annual cash from operations for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual cash from operations is $379.00M
What is Amneal Pharmaceuticals, Inc. annual cash from operations year-on-year change?
Over the past year, AMRX annual cash from operations has changed by +$111.87M (+61.07%)
What is Amneal Pharmaceuticals, Inc. quarterly cash from operations?
The current quarterly cash from operations of AMRX is $83.82M
What is the all-time high quarterly cash from operations for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly cash from operations is $259.65M
What is Amneal Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
Over the past year, AMRX quarterly cash from operations has changed by +$44.16M (+111.36%)
What is Amneal Pharmaceuticals, Inc. TTM cash from operations?
The current TTM cash from operations of AMRX is $351.01M
What is the all-time high TTM cash from operations for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high TTM cash from operations is $478.10M
What is Amneal Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
Over the past year, AMRX TTM cash from operations has changed by +$260.97M (+289.83%)